Background Image
Table of Contents Table of Contents
Previous Page  8 / 72 Next Page
Information
Show Menu
Previous Page 8 / 72 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016

62

AFRICA

Table 2 summarises the antenatal risk factors (as reported

in the MDNF) as documented at the first antenatal visit of the

pregnant mother. Some patients had more than one risk factor.

Ninety-two (78%) patients attended antenatal clinics, but only

44.3% of patients booked for antenatal care before 20 weeks’

gestation. Fig. 2 describes the level of antenatal care received by

the women who died. Forty (33.7%) mothers delivered vaginally,

31 (26.3%) by Caesarean section, and 47 (39.8%) mothers were

undelivered. The average gestation at delivery was 32 weeks.

Fifty-one (71.8%) babies were born preterm (

<

37 weeks’

gestation). The average birth weight of babies born alive was

2 558 g. Of the babies born alive, 37 (64.5%) were low birth-

weight (

<

2.5 kg) babies.

Cardiovascular conditions and co-morbidities

leading to death

An electrocardiogram and echocardiogram was performed in

only 42.9% (

n

=

50) and 34% (

n

=

40) of patients, respectively.

The mean heart rate of the patients who died was 115 beats per

minute (Table 1); 19 were hypertensive (systolic BP

>

140 mmHg)

and eight were hypotensive (systolic BP

<

100 mmHg).

The majority of women (69%,

n

=

71) died after delivery, while

the remaining 47 (31%) died during the antenatal period. For the

mothers who died in the postpartum period, death occurred

11

±

10.7 days postpartum. Seventy-two per cent of mothers

presented to the health institutions in a critically ill condition,

while 6% of the mothers were dead on arrival. The maternal

deaths occurred at the following health localities: community

health clinics, five patients (4.12%); level one hospital, 25

(21.7%); level two hospitals, 34 (28.9%); level three hospitals, 50

(42.3%) and private hospitals, four (3.1%).

The diagnosis contributing to cardiac death is illustrated in

Fig. 3. PPCM (34%) and complications of RHD, which includes

un-operated cases, as well as cases with prosthetic valve disease

(25.3%), were the most important diagnoses leading to maternal

death.

PPCM and other cardiomyopathy

There were 41 deaths due to PPCM. All cases were newly

diagnosed as none of the maternal records documented a

previous history of cardiomyopathy. Twelve (29.3%) deaths

occurred at level three institutions, 14 (34.2%) at level two

facilities and 15 (36.6%) at level one or community health clinics.

Twenty (48.8%) mothers presented with acute symptoms in the

postpartum period. Death occurred in nine (22.0%) patients who

were undelivered, and 32 (78.1%) were postpartum.

The most important antenatal co-morbidities identified

among the women who died due to a cardiomyopathy were:

hypertension, 22 patients (53.7%), HIV infection, 17 (41.5%)

and anaemia, 15 (36.6%). Twenty (48.8%) mothers however had

a haemoglobin level of

<

10 g/dl when they presented in acute

cardiac failure. In most cases, a clinical diagnosis was made, in

only 12 (30%) cases was an electrocardiogram performed, and

an echocardiogram was done in five (13%) cases to confirm

diagnosis of a cardiomyopathy.

Rheumatic heart disease

There were 35 maternal death files due to complications of RHD

available for assessment. There were 19 cases of valvular heart

disease, four deaths due to complications of prosthetic heart

valves (presumed to be rheumatic in origin in this South African

population), two deaths due to infective endocarditis and five

cases of underlying valvular lesions complicated by pulmonary

hypertension. Mitral stenosis was the most common valvular

lesion contributing to maternal death (

>

50% of cases with

valvular lesions), followed by severe tricuspid incompetence (

n

=

4), mixed mitral valve disease (

n

=

2), aortic stenosis (n

=

2), and

one case of isolated severe mitral regurgitation.

All four patients with mechanical heart valve prostheses

died due to valve thrombosis. Two patients were non-compliant

with anti-coagulant medications. One patient was treated with

Peripartum cardiomyopathy

Prosthetic heart valves

Pulmonary hypertension

Congenital heart disease

Myocardial infarction

Infective endocarditis

Other

Other cardiomyopathies

Rheumatic heart disease

41 (34%)

19 (6.2%)

2 (1.7%)

3 (2.5%)

19 (16%)

10

(8.4%)

9 (7.6%)

9 (7.6%)

6 (5.1%)

Fig. 3.

Cardiovascular conditions contributing to cardiac death

(

n

=

118).

Specialist: a person registered with the Health Professionals Council of

South Africa (HPCSA) in an appropriate speciality.

General practitioner/medical officer: a doctor with a medical degree

registered with the HPCSA.

Professional nurse: a person who is qualified as a midwife.

Advanced midwife: a professional nurse who has completed a further

year of training in midwifery.

Specialist

General practitioner/

medical officer

Advanced midwife/

professional nurse

70

60

50

40

30

20

10

0

%

Number

Fig. 2.

Antenatal care provider.

Table 2. Antenatal risk factors (

n

=

118)

Risk factor

Number (%)

With known heart disease

46 (39.7)

Smoking (past and current)

11 (9.3)

Tuberculosis (past and current)

8 (6.8)

Hypertension

43 (36.4)

Proteinuria in current pregnancy

22 (18.6)

Glycosuria in current pregnancy

12 (10.2)

Anaemia (haemoglobin

<

10 g/l)

30 (26.8)